Literature DB >> 6244146

The interaction of relaxin with the rat uterus. I. Effect on cyclic nucleotide levels and spontaneous contractile activity.

B M Sanborn, H S Kuo, N W Weisbrodt, O D Sherwood.   

Abstract

Three different preparations of relaxin elevated cAMP levels in isometrically suspended uterine strips obtained from estrogen-primed female rats in the presence of phosphodiesterase inhibitors. The effect was time and dose dependent, with maximal response at 20 min and 1 microgram/ml, respectively. No changes in cGMP levels were observed. No significant response was observed in ileum, vas deferens, epididymis, or testicular capsule. In the absence of phosphodiesterase inhibitors, relaxin markedly suppressed spontaneous contractile activity at doses of 0.36 and 0.96 microgram/ml but did not elevate cAMP in this dose range. While the beta-adrenergic antagonist propranolol suppressed both the relaxant action and cAMP stimulation promoted by isoproterenol, it did not interfere with the effect of relaxin on these same parameters. Relaxin is therefore capable of relaxing uterine muscle and elevating cAMP by mechanisms which probably do not require beta-adrenergic mediation. It is not clear at present whether the effects of relaxin on cAMP levels and contractile activity are causally related.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244146     DOI: 10.1210/endo-106-4-1210

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.

Authors:  M L Halls; E T van der Westhuizen; R A D Bathgate; R J Summers
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

Review 2.  Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation.

Authors:  Michelle L Halls
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Antagonism of relaxin by glibenclamide in the uterus of the rat in vivo.

Authors:  S J Downing; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

4.  Proceedings of the British Pharmacological Society Meeting. 3rd-5th January 1990. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

5.  Proceedings of the British Pharmacological Society Meeting. Sheffield, 18-20th April 1990.

Authors: 
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

6.  Relaxin stimulates multiple signaling pathways: activation of cAMP, PI3K, and PKCzeta in THP-1 cells.

Authors:  Carmen W Dessauer; Bao T Nguyen
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

7.  Increase in cyclic AMP levels by relaxin in newborn rhesus monkey uterus cell culture.

Authors:  S M Kramer; U E Gibson; B M Fendly; M A Mohler; D W Drolet; P D Johnston
Journal:  In Vitro Cell Dev Biol       Date:  1990-06

Review 8.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

9.  Cellular localization of the inhibitory action of relaxin against uterine spasm.

Authors:  S J Hughes; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

10.  The lack of a role for potassium channel opening in the action of relaxin in the rat isolated uterus; a comparison with levcromakalim and salbutamol.

Authors:  S J Hughes; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.